246 related articles for article (PubMed ID: 29705862)
1. Cardiovascular Risk in Cancer Survivors.
Agmon Nardi I; Iakobishvili Z
Curr Treat Options Cardiovasc Med; 2018 Apr; 20(6):47. PubMed ID: 29705862
[TBL] [Abstract][Full Text] [Related]
2. Cancer and cardiovascular disease: can understanding the mechanisms of cardiovascular injury guide us to optimise care in cancer survivors?
Truong LL; Scott L; Pal RS; Jalink M; Gunasekara S; Wijeratne DT
Ecancermedicalscience; 2022; 16():1430. PubMed ID: 36158986
[TBL] [Abstract][Full Text] [Related]
3. Greenspace, Inflammation, Cardiovascular Health, and Cancer: A Review and Conceptual Framework for Greenspace in Cardio-Oncology Research.
Bikomeye JC; Beyer AM; Kwarteng JL; Beyer KMM
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206610
[TBL] [Abstract][Full Text] [Related]
4. Cardio-Oncology: A Myriad of Relationships Between Cardiovascular Disease and Cancer.
Wang Y; Wang Y; Han X; Sun J; Li C; Adhikari BK; Zhang J; Miao X; Chen Z
Front Cardiovasc Med; 2022; 9():727487. PubMed ID: 35369296
[TBL] [Abstract][Full Text] [Related]
5. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
Tajiri K; Aonuma K; Sekine I
Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2.
Manolis AA; Manolis TA; Mikhailidis DP; Manolis AS
Expert Opin Drug Saf; 2018 Sep; 17(9):893-915. PubMed ID: 30126303
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Complications in the Adult Bone Marrow Transplant Patient.
Tuzovic M; Mead M; Young PA; Schiller G; Yang EH
Curr Oncol Rep; 2019 Mar; 21(3):28. PubMed ID: 30826891
[TBL] [Abstract][Full Text] [Related]
8. Organization and implementation of a cardio-oncology program.
Fiuza M; Ribeiro L; Magalhães A; Sousa AR; Nobre Menezes M; Jorge M; Costa L; Pinto FJ
Rev Port Cardiol; 2016 Sep; 35(9):485-94. PubMed ID: 27503589
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).
Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I
BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548
[TBL] [Abstract][Full Text] [Related]
10. Challenges Predicting the Cardiovascular Future for Survivors of Childhood Cancer.
Mulrooney DA
Cancer Epidemiol Biomarkers Prev; 2022 Mar; 31(3):515-517. PubMed ID: 35253045
[TBL] [Abstract][Full Text] [Related]
11. Cardio-oncology, the myth of Sisyphus, and cardiovascular disease in breast cancer survivors.
Mavrogeni SI; Sfendouraki E; Markousis-Mavrogenis G; Rigopoulos A; Noutsias M; Kolovou G; Angeli C; Tousoulis D
Heart Fail Rev; 2019 Nov; 24(6):977-987. PubMed ID: 31134427
[TBL] [Abstract][Full Text] [Related]
12. Personalizing cardiovascular disease prevention among breast cancer survivors.
Singla A; Kumar G; Bardia A
Curr Opin Cardiol; 2012 Sep; 27(5):515-24. PubMed ID: 22874128
[TBL] [Abstract][Full Text] [Related]
13. Cardio-Oncology: A Focused Review of Anthracycline-, Human Epidermal Growth Factor Receptor 2 Inhibitor-, and Radiation-Induced Cardiotoxicity and Management.
Domercant J; Polin N; Jahangir E
Ochsner J; 2016; 16(3):250-6. PubMed ID: 27660573
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.
Mehta LS; Watson KE; Barac A; Beckie TM; Bittner V; Cruz-Flores S; Dent S; Kondapalli L; Ky B; Okwuosa T; Piña IL; Volgman AS;
Circulation; 2018 Feb; 137(8):e30-e66. PubMed ID: 29437116
[TBL] [Abstract][Full Text] [Related]
15. Opportunities for improved cardiovascular disease prevention in oncology patients.
Bravo-Jaimes K; Marcellon R; Varanitskaya L; Kim PY; Iliescu C; Gilchrist SC; Baldassarre LA; Manisty C; Ghosh AK; Guha A; Lopez-Mattei JC
Curr Opin Cardiol; 2020 Sep; 35(5):531-537. PubMed ID: 32649353
[TBL] [Abstract][Full Text] [Related]
16. Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study.
Hamood R; Hamood H; Merhasin I; Keinan-Boker L
J Cardiol; 2019 Apr; 73(4):280-291. PubMed ID: 30587455
[TBL] [Abstract][Full Text] [Related]
17. Cardiotoxicity among adult survivors suffered from childhood malignancies.
Petropoulos AC; Moschovi M
Hell J Nucl Med; 2019; 22 Suppl 2():34-40. PubMed ID: 31802042
[TBL] [Abstract][Full Text] [Related]
18. Rurality, Cardiovascular Risk Factors, and Early Cardiovascular Disease among Childhood, Adolescent, and Young Adult Cancer Survivors.
Noyd DH; Bailey A; Janitz A; Razzaghi T; Bouvette S; Beasley W; Baker A; Chen S; Bard D
Res Sq; 2024 Apr; ():. PubMed ID: 38645102
[TBL] [Abstract][Full Text] [Related]
19. Cardio-oncology: A Focus on Cardiotoxicity.
Koutsoukis A; Ntalianis A; Repasos E; Kastritis E; Dimopoulos MA; Paraskevaidis I
Eur Cardiol; 2018 Aug; 13(1):64-69. PubMed ID: 30310475
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Serum Biomarkers for Cardiological Risk Stratification and Insight into the Cardiac Management of the Patients With Hematological Malignancies Treated With Targeted Therapy.
Andreescu M
Cureus; 2023 Nov; 15(11):e49696. PubMed ID: 38033434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
